GlassScriptPhysician profile
Duncan Rc Scott
NPI 1568555795
$5,830.85
in general payments reported to CMS, 2019-2025
39 companies · $899 in 2025
The $899 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $882 · 2020: $584 · 2021: $803 · 2022: $1,095 · 2023: $963 · 2024: $605 · 2025: $899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,467.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $1,356.80 | 2019-2025 | Xtampza, Belbuca |
| Abbvie INC. | $550.02 | 2019-2025 | Ubrelvy, Qulipta |
| Tersera Therapeutics LLC | $467.45 | 2019-2025 | Prialt |
| Pfizer INC. | $306.87 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $292.89 | 2019-2022 | |
| Amgen INC. | $265.32 | 2019-2022 | |
| Medtronic, INC. | $251.44 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $234.81 | 2020-2023 | Relistor |
| Teva Pharmaceuticals USA, INC. | $197.65 | 2019-2025 | Ajovy |
| Lilly USA, LLC | $185.70 | 2019-2022 | |
| Spr Therapeutics, INC | $172.73 | 2022-2025 | Sprint Pns System |
| Forte Bio-Pharma LLC | $169.24 | 2019-2025 | Prolate, Nalocet, Tanlor |
| Vertex Pharmaceuticals Incorporated | $127.62 | 2024-2025 | |
| Boston Scientific Corporation | $109.19 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $87.72 | 2019-2020 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Duncan Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.